Please complete the CAPTCHA to continue
@alnylam.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Dan Schoen is listed as Global Market Access Strategy Leader | Driving Revenue Growth & Market Expansion | Expert in Pharmaceutical Market Access at Alnylam Pharmaceuticals, a company with 1542 employees, based in Arlington Heights, Illinois, United States. AeroLeads shows a work email signal at alnylam.com and a matched LinkedIn profile for Dan Schoen.
Dan Schoen previously worked as Director TTR Franchise, Global Market Access and Pricing at Alnylam Pharmaceuticals and Oncology Market Access c-MET Franchise Lead – Global Market Access & Pricing at Abbvie. Dan Schoen holds Master Of Business Administration - Mba from Lake Forest Graduate School Of Management.
This section adds company-level context without repeating Dan Schoen's masked contact details.
AeroLeads found 1 current-domain work email signal for Dan Schoen. Compare company email patterns before reaching out.
With nearly two decades in biopharmaceuticals, I specialize in shaping global market access strategies to optimize revenue and ensure patient access to transformative therapies. Currently, as Director TTR Franchise at Alnylam Pharmaceuticals (and Regional Access Lead for Partner Markets), I lead pricing and reimbursement strategies for Onpattro and Amvuttra, focusing on expanding indications and maximizing market entry effectiveness, with a keen focus on our initial launch into Cardiomyopathy.Previously at AbbVie, I led launch strategies for Teliso-V in NSCLC as the Oncology Market Access c-MET Franchise Lead. I excel in developing integrated access plans and business assessments that accelerate market adoption and enhance competitive positioning.My career spans strategic roles in global market access and pricing within oncology, immunology, and specialty/rare disease, emphasizing my ability to navigate complex market landscapes and drive revenue growth through innovative access strategies. I bring a proven track record in strategic leadership and cross-functional collaboration, essential for achieving market leadership in biopharmaceuticals.ROBUST EXPERTISEStrategic Pricing ▪ Market Access Strategy ▪ Product Launch Planning ▪ International Reference Pricing ▪ Value-based Pricing ▪ Contracting Strategy ▪ Cross-functional Leadership ▪ Revenue Optimization ▪ Financial Acumen ▪ Competitive Intelligence Analysis ▪ Stakeholder Management ▪ Market Segmentation ▪ Pricing Governance ▪ Healthcare Policy Analysis ▪ Commercial Strategy Development
Listed skills include Forecasting, Financial Modeling, Finance, Management, and 28 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Chicago/Cambridge
I lead pricing and reimbursement strategies globally for Onpattro and Amvuttra, focusing particularly on the cardiomyopathy launch and expanding franchise indications, while providing critical access insights into pipeline development. I collaborate extensively across functions to develop and implement pricing strategies and launch sequencing, representing.
Chicago, Illinois, United States
I led the c-MET franchise at AbbVie, overseeing three pipeline assets, including Teliso-V in NSCLC, which will hopefully be AbbVie's inaugural solid tumor launch. In this role, I established and led the Value and Access Teams, responsible for developing integrated access strategies for each asset and the overall franchise. I directed solid tumor business.
Chicago, Illinois, United States
I oversaw the lifecycle strategy for Venetoclax at AbbVie, focusing on launch planning for Mantle Cell Lymphoma and renegotiations for r/r CLL indications. My role involved developing orphan strategies across various indications to ensure strategic market entry. I was responsible for managing LOE pricing strategy and solid tumor access plans for.
Chicago, Illinois, United States
I managed global price bands, launch sequencing, and International Reference Pricing (IRP) impacts for AbbVie's Hematology franchise, focusing on Venetoclax and Navitoclax. I led the launch efforts for Venetoclax, overseeing strategies for both monotherapy and combination therapy. My role included conducting lifecycle planning and indication sequencing.
Chicago
Provided vision and pricing insights for Humira and biosimilars, contributing to strategic pricing strategies pre and post loss of exclusivity. Recognized with a President's Award for impactful contributions to pricing strategy.
Chicago, Illinois, United States
Managed $900M P&L expenses and $1B inventory, supporting operational planning and deployment. Led financial analysis and strategic decision-making for market demand fluctuations.
Chicago
Guided financial support and insights for Abbott Nutrition Supply Chain operations. Led volume alignment efforts across Supply Chain and Commercial functional areas, optimizing planning processes.Finance Manager, Nutrition Supply ChainSr. Analyst, Long Range Planning (Nutrition International)FP&A Manager, Colombian Affiliate (Nutrition International)Sr..
San Francisco Bay Area
Analyzed financial statements for businesses, supervised business bankers, and achieved top ranking in Northern California division for sales performance.
Other employees you can reach at alnylam.com. View company contacts for 1542 employees →
Jill Hogan, Mha
Colleague at Alnylam PharmaceuticalsUnited States, United States
View →
CT
Carmine Tedesco
Colleague at Alnylam PharmaceuticalsCambridge, Massachusetts, United States, United States
View →
TN
Tim Noble
Colleague at Alnylam PharmaceuticalsSomerville, Massachusetts, United States, United States
View →
CS
Christine Schifone
Colleague at Alnylam PharmaceuticalsGreater Boston, United States
View →
QW
Qianfan Wang
Colleague at Alnylam PharmaceuticalsCambridge, Massachusetts, United States, United States
View →
KA
Khalid Alangari
Colleague at Alnylam PharmaceuticalsRiyadh, Riyadh, Saudi Arabia, Saudi Arabia
View →
PC
Paula Cavallieri
Colleague at Alnylam PharmaceuticalsSão Paulo, São Paulo, Brazil, Brazil
View →
JM
Jorge Marco
Colleague at Alnylam PharmaceuticalsZaragoza, Aragon, Spain, Spain
View →
AH
Angela Hernández Molina
Colleague at Alnylam PharmaceuticalsMadrid, Community Of Madrid, Spain, Spain
View →
DR
Divya Ravikumar
Colleague at Alnylam PharmaceuticalsBoston, Massachusetts, United States, United States
View →
Quick answers generated from the profile data available on this page.
Dan Schoen works for Alnylam Pharmaceuticals.
Dan Schoen is listed as Global Market Access Strategy Leader | Driving Revenue Growth & Market Expansion | Expert in Pharmaceutical Market Access at Alnylam Pharmaceuticals.
AeroLeads has found 1 work email signal at @alnylam.com for Dan Schoen at Alnylam Pharmaceuticals.
Dan Schoen is based in Arlington Heights, Illinois, United States while working with Alnylam Pharmaceuticals.
Dan Schoen has worked for Alnylam Pharmaceuticals, Abbvie, Baxter International Inc., Abbott, and Bank Of America.
Dan Schoen's colleagues at Alnylam Pharmaceuticals include Jill Hogan, Mha, Carmine Tedesco, Tim Noble, Christine Schifone, and Qianfan Wang.
You can use AeroLeads to view verified contact signals for Dan Schoen at Alnylam Pharmaceuticals, including work email, phone, and LinkedIn data when available.
Dan Schoen holds Master Of Business Administration - Mba from Lake Forest Graduate School Of Management.
Dan Schoen is listed with skills including Forecasting, Financial Modeling, Finance, Management, Financial Reporting, Financial Analysis, Analysis, and Auditing.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contactsCheck these profiles if this is not the Dan Schoen you were looking for.
